回到顶部
2024-12-19当前位置:网站首页 > 行业动态 > 数据共享 > 期刊杂志 >

丙泊酚复合瑞芬太尼麻醉对甲状腺术后患者头痛、头晕及恶心、呕吐

  [摘要]目的 探讨丙泊酚复合瑞芬太尼麻醉对甲状腺术后头晕、头痛、恶心、呕吐等的影响。方法 选取2016年1月~2017年1月我院收治的60例甲状腺手术患者作为研究对象,根据计算机随机化原则分为观察组(30例)和对照组(30例),观察组患者采用丙泊酚复合瑞芬太尼诱导麻醉,对照组患者采取七氟烷麻醉,比较两组患者术后不同时间点头痛、头晕及恶心、呕吐的情况。结果 观察组患者术后4、8 h的头晕、头痛发生率及恶心、呕吐发生率均低于对照组,差异有统计学意义(P0.05)。结论 甲状腺手术应用丙泊酚复合瑞芬太尼麻醉,能有效控制术后头晕、头痛及恶心、呕吐的发生。

 [关键词]丙泊酚;七氟烷;甲状腺手术;麻醉

 [中图分类号] R541.4 [文献标识码] A [文章编号] 1674-4721(2019)3(c)-0098-04

 [Abstract] Objective To investigate the effects of Propofol combined with Remifentanil anesthesia on dizziness, headache, nausea and vomiting after thyroid surgery. Methods A total of 60 patients with thyroid surgery admitted to our hospital from January 2016 to January 2017 were selected as the subjects, and divided into observation group (30 cases) and control group (30 cases) on the principle of computer randomization. Propofol combined with Remifentanil induced in the observation group. In the control group, Sevoflurane anesthesia was used. The incidence of headache, dizziness, nausea and vomiting at different time points were compared between the two groups. Results The incidence of dizziness, headache, nausea and vomiting were lower than those of control group after operation of 4 h and 8 h (P0.05),具有可比性。本研究经我院医学伦理委员会批准同意, 百拇医药(丁杰夫) 第 1 2 3 页 下一页
 百拇医药网 http://www.100md.com/html/paper/1674-4721/2019/09/28.htm
上一篇:全身麻醉结合超声引导下椎旁神经阻滞在快速康复胸
下一篇:七氟醚静吸复合麻醉对腹腔镜下宫颈癌根治术患者炎症反应及麻醉效
Copyright © 2012-2024. All rights reserved  备案号:京ICP备06040839号-8  XML地图  模板巴巴
行业动态 | 生活保健 | 中医中药 | 美容天地

扫码关注公众号